CDIO

SEC source: 0001486189-23-000035 · primary_doc.xml · nonDerivative · entry 2

Lau Stanley K. · CIK 0001950824 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,701

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: Represents the settlement of RSUs, awarded for advisory services, which vested on August 31, 2023 through the issuance of shares of Common Stock

SEC source: 0001486189-23-000025 · primary_doc.xml · nonDerivative · entry 3

Philibert Robert · CIK 0001949924 · Director · Chief Medical Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See note (1)

Disclosed balance after: 1,649,792

F1 · ownership.direct: Robert Philibert a Director and Chief Medical Officer (CMO) of the registrant, is the direct owner of 41,601 of the securities of the registrant reported herein, owns and controls BD Holding Inc., the direct owner of 1,586,464 of the securities of the registrant reported herein, owns and controls Behavioral Diagnostics LLC, the direct owner of 14,126 of the securities of the registrant reported herein, and his spouse is the direct owner of 7,601of the securities of the registrant reported herein.

SEC source: 0001486189-23-000025 · primary_doc.xml · nonDerivative · entry 2

Philibert Robert · CIK 0001949924 · Director · Chief Medical Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See note (1)

Disclosed balance after: 1,649,692

F1 · ownership.direct: Robert Philibert a Director and Chief Medical Officer (CMO) of the registrant, is the direct owner of 41,601 of the securities of the registrant reported herein, owns and controls BD Holding Inc., the direct owner of 1,586,464 of the securities of the registrant reported herein, owns and controls Behavioral Diagnostics LLC, the direct owner of 14,126 of the securities of the registrant reported herein, and his spouse is the direct owner of 7,601of the securities of the registrant reported herein.

SEC source: 0001486189-23-000027 · primary_doc.xml · nonDerivative · entry 1

Dogan Meeshanthini · CIK 0001950789 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See note(3)

Disclosed balance after: 111,864

F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions with prices ranging from $0.55 to $0.56 inclusive. The reporting person undertakes to provide to Cardio Diagnostics Holdings Inc., any security holder of Cardio Diagnostics Holdings Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range of footnote (1) to this Form 4.

F3 · ownership.direct: These securities are held by the reporting person's spouse. The reporting person disclaims beneficial ownership of such securities except to the extent of her actual pecuniary interest therein.

SEC source: 0001486189-23-000026 · primary_doc.xml · nonDerivative · entry 1

Dogan Timur · CIK 0001950663 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 111,864

F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions with prices ranging from $0.55 to $0.56 inclusive. The reporting person undertakes to provide to Cardio Diagnostics Holdings Inc., any security holder of Cardio Diagnostics Holdings Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range of footnote (1) to this Form 4.

SEC source: 0001486189-23-000025 · primary_doc.xml · nonDerivative · entry 1

Philibert Robert · CIK 0001949924 · Director · Chief Medical Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See note(1)

Disclosed balance after: 1,631,792

F1 · ownership.direct: Robert Philibert a Director and Chief Medical Officer (CMO) of the registrant, is the direct owner of 41,601 of the securities of the registrant reported herein, owns and controls BD Holding Inc., the direct owner of 1,586,464 of the securities of the registrant reported herein, owns and controls Behavioral Diagnostics LLC, the direct owner of 14,126 of the securities of the registrant reported herein, and his spouse is the direct owner of 7,601of the securities of the registrant reported herein.

SEC source: 0001486189-23-000035 · primary_doc.xml · derivative · entry 5

Lau Stanley K. · CIK 0001950824 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Common Stock · Not disclosed shares

Expires 2024-01-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: Each RSU is the economic equivalent of one share of Cardio Diagnostics Holdings, Inc. common stock. On July 31, 2023, $2,000 in value of RSUs vested and were settled at the price of $1.21, which was the closing price of the Company Common Stock on the vesting date. The settlement shares are reflected in Table I.

F7 · price: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.

F6 · derivative.exercise_date: On July 1, 2023, the reporting person was awarded $24,000 in value of RSUs, $10,000 in value of which vested on July 1, 2023, $2,000 in value of which vested on July 31, 2023, $2,000 in value of which vested on August 31, 2023, and $2,000 in value of which vested on September 30, 2023. Subject to continued service with the Issuer on each respective vesting date, the RSUs will continue to vest as follows based on the closing price of the Issuers common stock on each respective vesting date: (i) $2,000 in value on October 31, 2023; (ii) $2,000 in value on November 30, 2023; (iii) $2,000 in value on December 31, 2023; and (iv) $2,000 in value on January 31, 2024.

F6 · derivative.expiration_date: On July 1, 2023, the reporting person was awarded $24,000 in value of RSUs, $10,000 in value of which vested on July 1, 2023, $2,000 in value of which vested on July 31, 2023, $2,000 in value of which vested on August 31, 2023, and $2,000 in value of which vested on September 30, 2023. Subject to continued service with the Issuer on each respective vesting date, the RSUs will continue to vest as follows based on the closing price of the Issuers common stock on each respective vesting date: (i) $2,000 in value on October 31, 2023; (ii) $2,000 in value on November 30, 2023; (iii) $2,000 in value on December 31, 2023; and (iv) $2,000 in value on January 31, 2024.

F7 · valueOwnedAfter: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.

SEC source: 0001486189-23-000035 · primary_doc.xml · nonDerivative · entry 1

Lau Stanley K. · CIK 0001950824 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,064

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the settlement of restricted stock units (RSUs), awarded for advisory services, which vested on July 31, 2023 through the issuance of shares of Common Stock.

SEC source: 0001486189-23-000023 · primary_doc.xml · derivative · entry 4

Lau Stanley K. · CIK 0001950824 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Common Stock · Not disclosed shares

Expires 2024-01-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_price: Each RSU is the economic equivalent of one share of Cardio Diagnostics Holdings, Inc. common stock. On July 1, 2023, $10,000 in value of RSUs vested and were settled at the price of $1.19, which was the closing price of the Companys Common Stock on the vesting date. The settlement shares are reflected in Table I.

F5 · price: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.

F7 · derivative.exercise_date: On July 1, 2023, the reporting person was awarded $24,000 in value of RSUs, $10,000 in value of which vested on July 1, 2023. Subject to continued service with the Issuer on each respective vesting date, the RSUs will continue to vest as follows based on the closing price of the Issuers common stock on each respective vesting date: (i) $2,000 in value on July 31, 2023, (ii) $2,000 in value on August 31, 2023, (iii) $2,000 in value on September 30, 2023; (iv) $2,000 in value on October 31, 2023; (v) $2,000 in value on November 30, 2023; (vi) $2,000 in value on December 31, 2023 and (vii) $2,000 in value on January 31, 2024.

F7 · derivative.expiration_date: On July 1, 2023, the reporting person was awarded $24,000 in value of RSUs, $10,000 in value of which vested on July 1, 2023. Subject to continued service with the Issuer on each respective vesting date, the RSUs will continue to vest as follows based on the closing price of the Issuers common stock on each respective vesting date: (i) $2,000 in value on July 31, 2023, (ii) $2,000 in value on August 31, 2023, (iii) $2,000 in value on September 30, 2023; (iv) $2,000 in value on October 31, 2023; (v) $2,000 in value on November 30, 2023; (vi) $2,000 in value on December 31, 2023 and (vii) $2,000 in value on January 31, 2024.

F5 · valueOwnedAfter: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.

SEC source: 0001486189-23-000023 · primary_doc.xml · nonDerivative · entry 2

Lau Stanley K. · CIK 0001950824 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,411

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · kind: Represents the settlement of restricted stock units (RSUs) that vested on July 1, 2023 through the issuance of shares of Common Stock.

SEC source: 0001486189-23-000023 · primary_doc.xml · derivative · entry 3

Lau Stanley K. · CIK 0001950824 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Common Stock · Not disclosed shares

Expires 2023-12-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU is the economic equivalent of one share of Cardio Diagnostics Holdings, Inc. common stock. On June 30, 2023, $25,000 in value of RSUs vested and were settled at the price of $1.19, which was the closing price of the Companys Common Stock on the vesting date. The settlement shares are reflected in Table I.

F5 · price: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.

F4 · derivative.exercise_date: On June 19, 2023, the reporting person was awarded $50,000 in value of RSUs, $25,000 in value of which vested on June 30, 2023. Subject to continued service with the Issuer on each respective vesting date, the RSUs will continue to vest as follows based on the closing price of the Issuers common stock on each respective vesting date: (i) $12,500 in value on September 30, 2023; and (ii) $12,500 in value on December 31, 2023.

F4 · derivative.expiration_date: On June 19, 2023, the reporting person was awarded $50,000 in value of RSUs, $25,000 in value of which vested on June 30, 2023. Subject to continued service with the Issuer on each respective vesting date, the RSUs will continue to vest as follows based on the closing price of the Issuers common stock on each respective vesting date: (i) $12,500 in value on September 30, 2023; and (ii) $12,500 in value on December 31, 2023.

F5 · valueOwnedAfter: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.

SEC source: 0001486189-23-000023 · primary_doc.xml · nonDerivative · entry 1

Lau Stanley K. · CIK 0001950824 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,008

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the settlement of restricted stock units (RSUs) that vested on June 30, 2023 through the issuance of shares of Common Stock.

SEC source: 0001486189-23-000022 · primary_doc.xml · derivative · entry 2

Intrater James · CIK 0001950394 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Common Stock · Not disclosed shares

Expires 2023-12-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU is the economic equivalent of one share of Cardio Diagnostics Holdings, Inc. common stock. On June 30, 2023, $25,000 in value of RSUs vested and were settled at the price of $1.19, which was the closing price of the Companys Common Stock on the vesting date. The settlement shares are reflected in Table I.

F4 · price: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.

F3 · derivative.exercise_date: On June 19, 2023, the reporting person was awarded $50,000 in value of RSUs, $25,000 in value of which vested on June 30, 2023. Subject to continued service with the Issuer on each respective vesting date, the RSUs will continue to vest as follows based on the closing price of the Issuers common stock on each respective vesting date: (i) $12,500 in value on September 30, 2023; and (ii) $12,500 in value on December 31, 2023.

F3 · derivative.expiration_date: On June 19, 2023, the reporting person was awarded $50,000 in value of RSUs, $25,000 in value of which vested on June 30, 2023. Subject to continued service with the Issuer on each respective vesting date, the RSUs will continue to vest as follows based on the closing price of the Issuers common stock on each respective vesting date: (i) $12,500 in value on September 30, 2023; and (ii) $12,500 in value on December 31, 2023.

F4 · valueOwnedAfter: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.

SEC source: 0001486189-23-000022 · primary_doc.xml · nonDerivative · entry 1

Intrater James · CIK 0001950394 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,208

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the settlement of restricted stock units (RSUs) that vested on June 30, 2023 through the issuance of shares of Common Stock.

SEC source: 0001486189-23-000021 · primary_doc.xml · derivative · entry 2

Sim Brandon · CIK 0001813532 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Common Stock · Not disclosed shares

Expires 2023-12-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU is the economic equivalent of one share of Cardio Diagnostics Holdings, Inc. common stock. On June 30, 2023, $25,000 in value of RSUs vested and were settled at the price of $1.19, which was the closing price of the Companys Common Stock on the vesting date. The settlement shares are reflected in Table I.

F4 · price: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.

F3 · derivative.exercise_date: On June 19, 2023, the reporting person was awarded $50,000 in value of RSUs, $25,000 in value of which vested on June 30, 2023. Subject to continued service with the Issuer on each respective vesting date, the RSUs will continue to vest as follows based on the closing price of the Issuers common stock on each respective vesting date: (i) $12,500 in value on September 30, 2023; and (ii) $12,500 in value on December 31, 2023.

F3 · derivative.expiration_date: On June 19, 2023, the reporting person was awarded $50,000 in value of RSUs, $25,000 in value of which vested on June 30, 2023. Subject to continued service with the Issuer on each respective vesting date, the RSUs will continue to vest as follows based on the closing price of the Issuers common stock on each respective vesting date: (i) $12,500 in value on September 30, 2023; and (ii) $12,500 in value on December 31, 2023.

F4 · valueOwnedAfter: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.

SEC source: 0001486189-23-000021 · primary_doc.xml · nonDerivative · entry 1

Sim Brandon · CIK 0001813532 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,008

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the settlement of restricted stock units (RSUs) that vested on June 30, 2023 through the issuance of shares of Common Stock.

SEC source: 0001486189-23-000020 · primary_doc.xml · derivative · entry 2

Levy Oded · CIK 0001950696 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Common Stock · Not disclosed shares

Expires 2023-12-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU is the economic equivalent of one share of Cardio Diagnostics Holdings, Inc. common stock. On June 30, 2023, $25,000 in value of RSUs vested and were settled at the price of $1.19, which was the closing price of the Companys Common Stock on the vesting date. The settlement shares are reflected in Table I.

F4 · price: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.

F3 · derivative.exercise_date: On June 19, 2023, the reporting person was awarded $50,000 in value of RSUs, $25,000 in value of which vested on June 30, 2023. Subject to continued service with the Issuer on each respective vesting date, the RSUs will continue to vest as follows based on the closing price of the Issuers common stock on each respective vesting date: (i) $12,500 in value on September 30, 2023; and (ii) $12,500 in value on December 31, 2023.

F3 · derivative.expiration_date: On June 19, 2023, the reporting person was awarded $50,000 in value of RSUs, $25,000 in value of which vested on June 30, 2023. Subject to continued service with the Issuer on each respective vesting date, the RSUs will continue to vest as follows based on the closing price of the Issuers common stock on each respective vesting date: (i) $12,500 in value on September 30, 2023; and (ii) $12,500 in value on December 31, 2023.

F4 · valueOwnedAfter: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.

SEC source: 0001486189-23-000020 · primary_doc.xml · nonDerivative · entry 1

Levy Oded · CIK 0001950696 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,008

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Represents the settlement of restricted stock units (RSUs) that vested on June 30, 2023 through the issuance of shares of Common Stock.

SEC source: 0001486189-23-000017 · primary_doc.xml · derivative · entry 1

Abdullahi Khullani · CIK 0001950779 · VP of Revenue and Strategy

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,000

Underlying: Common Stock · 66,000 shares

Expires 2033-06-23

SEC source: 0001486189-23-000016 · primary_doc.xml · derivative · entry 1

Luqman Elisa V · CIK 0001486189 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,750

Underlying: Common Stock · 57,750 shares

Expires 2033-06-23

SEC source: 0001486189-23-000015 · primary_doc.xml · derivative · entry 1

Dogan Timur · CIK 0001950663 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 156,750

Underlying: Common Stock · 156,750 shares

Expires 2033-06-23

SEC source: 0001486189-23-000013 · primary_doc.xml · derivative · entry 1

Hosseinion Warren · CIK 0001438327 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 123,750

Underlying: Common Stock · 123,750 shares

Expires 2033-06-23

SEC source: 0001486189-23-000014 · primary_doc.xml · derivative · entry 1

Philibert Robert · CIK 0001949924 · Director · Chief Medical Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 148,500

Underlying: Common Stock · 148,500 shares

Expires 2033-06-23

SEC source: 0001486189-23-000012 · primary_doc.xml · derivative · entry 1

Dogan Meeshanthini · CIK 0001950789 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 272,250

Underlying: Common Stock · 272,250 shares

Expires 2033-06-23

SEC source: 0001486189-23-000019 · primary_doc.xml · derivative · entry 2

Dogan Timur · CIK 0001950663 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · See note (1)

Disclosed balance after: 272,250

Underlying: Common Stock · 272,250 shares

Expires 2033-06-23

F1 · ownership.direct: These securities are held by the reporting person's spouse. The reporting person disclaims beneficial ownership of such securities except to the extent of his actual pecuniary interest therein.

SEC source: 0001486189-23-000019 · primary_doc.xml · derivative · entry 1

Dogan Timur · CIK 0001950663 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 157,750

Underlying: Common Stock · 157,750 shares

Expires 2033-06-23

SEC source: 0001486189-23-000018 · primary_doc.xml · derivative · entry 2

Dogan Meeshanthini · CIK 0001950789 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Indirect · See note (1)

Disclosed balance after: 157,750

Underlying: Common Stock · 157,750 shares

Expires 2033-06-23

F1 · ownership.direct: These securities are held by the reporting person's spouse. The reporting person disclaims beneficial ownership of such securities except to the extent of her actual pecuniary interest therein.

SEC source: 0001486189-23-000018 · primary_doc.xml · derivative · entry 1

Dogan Meeshanthini · CIK 0001950789 · Director · Chief Executive Officer · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 272,250

Underlying: Common Stock · 272,250 shares

Expires 2033-06-23

SEC source: 0001486189-23-000039 · primary_doc.xml · derivative · entry 2

Dogan Timur · CIK 0001950663 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · See note (1)

Disclosed balance after: 272,250

Underlying: Common Stock · 272,250 shares

Expires 2033-06-23

F1 · ownership.direct: These securities are held by the reporting person's spouse. The reporting person disclaims beneficial ownership of such securities except to the extent of his actual pecuniary interest therein.

SEC source: 0001486189-23-000039 · primary_doc.xml · derivative · entry 1

Dogan Timur · CIK 0001950663 · Chief Technology Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 156,750

Underlying: Common Stock · 156,750 shares

Expires 2033-06-23

SEC source: 0001486189-23-000011 · primary_doc.xml · derivative · entry 1

Lau Stanley K. · CIK 0001950824 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Common Stock · Not disclosed shares

Expires 2023-12-31

F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents the contingent right to receive one share of common stock upon vesting of the RSU.

F2 · reported_value: Subject to continued service with the Issuer on each respective vesting date, the RSUs will vest as follows based on the closing price of the Issuers common stock on each respective vesting date: (i) $25,000 in value on June 30, 2023; (ii) $12,500 in value on September 30, 2023; and (iii) $12,500 in value on December 31, 2023.

F3 · price: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.

F2 · valueOwnedAfter: Subject to continued service with the Issuer on each respective vesting date, the RSUs will vest as follows based on the closing price of the Issuers common stock on each respective vesting date: (i) $25,000 in value on June 30, 2023; (ii) $12,500 in value on September 30, 2023; and (iii) $12,500 in value on December 31, 2023.

SEC source: 0001486189-23-000010 · primary_doc.xml · derivative · entry 1

Intrater James · CIK 0001950394 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Common Stock · Not disclosed shares

Expires 2023-12-31

F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents the contingent right to receive one share of common stock upon vesting of the RSU.

F2 · reported_value: Subject to continued service with the Issuer on each respective vesting date, the RSUs will vest as follows based on the closing price of the Issuers common stock on each respective vesting date: (i) $25,000 in value on June 30, 2023; (ii) $12,500 in value on September 30, 2023; and (iii) $12,500 in value on December 31, 2023.

F3 · price: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.

F2 · valueOwnedAfter: Subject to continued service with the Issuer on each respective vesting date, the RSUs will vest as follows based on the closing price of the Issuers common stock on each respective vesting date: (i) $25,000 in value on June 30, 2023; (ii) $12,500 in value on September 30, 2023; and (iii) $12,500 in value on December 31, 2023.

SEC source: 0001486189-23-000009 · primary_doc.xml · derivative · entry 1

Sim Brandon · CIK 0001813532 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Common Stock · Not disclosed shares

Expires 2023-12-31

F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents the contingent right to receive one share of common stock upon vesting of the RSU.

F2 · reported_value: Subject to continued service with the Issuer on each respective vesting date, the RSUs will vest as follows based on the closing price of the Issuers common stock on each respective vesting date: (i) $25,000 in value on June 30, 2023; (ii) $12,500 in value on September 30, 2023; and (iii) $12,500 in value on December 31, 2023.

F3 · price: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.

F2 · valueOwnedAfter: Subject to continued service with the Issuer on each respective vesting date, the RSUs will vest as follows based on the closing price of the Issuers common stock on each respective vesting date: (i) $25,000 in value on June 30, 2023; (ii) $12,500 in value on September 30, 2023; and (iii) $12,500 in value on December 31, 2023.

SEC source: 0001486189-23-000008 · primary_doc.xml · derivative · entry 1

Levy Oded · CIK 0001950696 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: Not disclosed

Underlying: Common Stock · Not disclosed shares

Expires 2023-12-31

F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents the contingent right to receive one share of common stock upon vesting of the RSU.

F2 · reported_value: Subject to continued service with the Issuer on each respective vesting date, the RSUs will vest as follows based on the closing price of the Issuers common stock on each respective vesting date: (i) $25,000 in value on June 30, 2023, (ii) $12,500 in value on September 30, 2023, and (iii) $12,500 in value on December 31, 2023.

F3 · price: The RSUs were granted pursuant to the Issuers 2022 Equity Incentive Plan.

F2 · valueOwnedAfter: Subject to continued service with the Issuer on each respective vesting date, the RSUs will vest as follows based on the closing price of the Issuers common stock on each respective vesting date: (i) $25,000 in value on June 30, 2023, (ii) $12,500 in value on September 30, 2023, and (iii) $12,500 in value on December 31, 2023.

SEC source: 0001079973-22-001363 · ownership.xml · derivative · entry 2

Mana Capital LLC · CIK 0001896528 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,500,000 shares

Expires 2027-10-25

F1 · price: Pursuant to the terms of the Subscription Agreement and the Second Amended and Restated Subscription Agreement and Letter Agreement between the Reporting Person and the Issuer (the "Agreements"), the Reporting Person transferred all of the common stock and private warrants it acquired in connection with the Issuer's initial public offering to permitted transferees with no consideration in compliance with the Agreements.

SEC source: 0001079973-22-001363 · ownership.xml · nonDerivative · entry 1

Mana Capital LLC · CIK 0001896528 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

F1 · price: Pursuant to the terms of the Subscription Agreement and the Second Amended and Restated Subscription Agreement and Letter Agreement between the Reporting Person and the Issuer (the "Agreements"), the Reporting Person transferred all of the common stock and private warrants it acquired in connection with the Issuer's initial public offering to permitted transferees with no consideration in compliance with the Agreements.

SEC source: 0001079973-21-001187 · ownership.xml · nonDerivative · entry 1

Mana Capital LLC · CIK 0001896528 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,565,000

F1 · price: Pursuant to the terms of the Second Amended and Restated Subscription Agreement between the Reporting Person and the Issuer, the Reporting Person was issued a total of 75,000 shares of Common Stock in connection with the partial exercise by the underwriters of the over-allotment option.